Vetoquinol SA, a prominent player in the animal health industry, is headquartered in France and operates extensively across Europe, North America, and Asia. Founded in 1933, the company has established itself as a trusted provider of veterinary pharmaceuticals and nutritional products, focusing on the health and well-being of pets and livestock. With a diverse portfolio that includes anti-infectives, pain management solutions, and nutritional supplements, Vetoquinol stands out for its commitment to innovation and quality. The company’s dedication to research and development has led to significant advancements in animal care, positioning it as a leader in the veterinary market. Notable achievements include a strong global presence and a reputation for reliability among veterinarians and pet owners alike.
How does Vetoquinol SA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Vetoquinol SA's score of 28 is lower than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Vetoquinol SA, headquartered in France, currently does not report specific carbon emissions data for the most recent year, as indicated by the absence of emissions figures. The company is identified as a current subsidiary and does not inherit emissions data from a parent organization. In terms of climate commitments, Vetoquinol SA has not established documented reduction targets or initiatives, nor does it participate in recognised frameworks such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). This lack of specific targets suggests that the company may still be in the early stages of formalising its climate strategy. As a player in the veterinary pharmaceutical industry, Vetoquinol SA is positioned within a sector increasingly focused on sustainability and carbon reduction. However, without concrete emissions data or reduction commitments, it remains unclear how the company plans to address its carbon footprint in the future.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Vetoquinol SA has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.


You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.